Prevalence, care, and outcomes for patients with diet-controlled diabetes in general practice: Cross sectional survey

Lancet

Volumn 364, Issue 9432, 2004, Pages 423-428

  Hippisley Cox, J ^a   Pringle, M ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; HEMOGLOBIN A1C;

ADULT; AGED; BLOOD PRESSURE; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DIET; FEMALE; FOOT; GENERAL PRACTICE; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOMES RESEARCH; PATIENT CARE; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PULSE RATE; RECORDING; REVIEW; SCREENING TEST; SMOKING; UNITED KINGDOM;

EID: 3843120160     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16765-2     Document Type: Article

References (30)

1. Nathan D. Some answers, more controversy, from UKPDS. Lancet. 352:1998;832-833
2. NICE. Guidance on the use of glitazones for the treatment of type 2 diabetes. 2003;22 NICE, London
3. University Group Diabetes Program. A study of the effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 1970; 19: 747-830.
4. Research Group. DCCT. The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Eng J Med. 329:1993;978-986
5. United Kingdom Prospective Diabetes Study Group. United Kingdom prospective diabetes study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ 1995; 310: 83-88.
6. United Kingdom Diabetes Study (UKPDS) Group. @ Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet 1998; 352: 837-853.
7. Stratton I, Adler A, Neil A, Matthews D. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35); prospective observational study. BMJ. 321:2000;405-412
8. Cooper ME, Johnston CI. Optimizing treatment of hypertension in patients with diabetes. JAMA. 283:2000;3177-3179
9. Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 321:2000;412-419
10. Gray A, Clarke P, Farmer A, Holman R, United Kingdom Prospective Diabetes Study G. Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63). BMJ. 325:2002;860
11. The Department of Health. The National Service Framework for Diabetes - the delivery strategy. 2003;Department of Health, London
12. The NHS Confederation. The New GMS Contract. 2003;108 The NHS Confederation, London
13. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 281:1999;2005-2012
14. Stovring H, Andersen M, Beck-Neilsen H, Green A, Vach W. Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database. Lancet. 362:2003;537-538
15. Wills C, Scott A, Swift P, Davies M, Mackie A, Mansell P. Retrospective review of care and outcomes in young adults with type 1 diabetes. BMJ. 327:2003;260-261
16. Townsend P. Deprivation. J Soc Pol. 16:1987;12546
17. Office of National Statistics. Key Health Statistics in General Practice. London: Office of National Statistics, 2000.
18. Roper NA, Bilous RW, Kelly WF, Unwin NC, Connolly VM. Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. BMJ. 322:2001;1389-1393
19. NHSIA. Preferred terms in primary care practice-based registers. 2003;38 NHSIA, London
20. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. Diabetes Care. 20:1997;614-620
21. Connolly V, Unwin N, Sherriff P, Bilous R, Kelly W. Diabetes prevalence and socioeconomic status: a population based study showing increased prevalence of type 2 diabetes mellitus in deprived areas. JECH. 54:2000;173-177
22. Gray J, Orr D, Majeed A. Use of Read codes in diabetes management in a south London primary care group: implications for establishing disease registers. BMJ. 326:2003;1130
23. Goyder E, Hammersley V. Explaining variations in reported diabetes prevalence in general practice: how much variation is explained by differences between practice populations? Br J Gen Pract. 53:2003;642-643
24. Guthrie B, Emslie-Smith A, Morris A, Fahey T, Sullivan F. Quality measurement of care for people with type 2 diabetes in Tayside, Scotland: implications for the new UK general practice contract. Br J Gen Pract. 53:2003;709-713
25. Hippisley-Cox J, Pringle M, Cater R, et al. Electronic record in primary care: regression or progression? Cross-sectional survey. BMJ. 326:2003;1439-1443
26. Ko G, Chan J, Chow C, Yeung V, Li Y, Cockram C. Phenformin-induced lactic acidosis: an almost forgotten complication of treatment with biguanides. Br J Health Med. 54:1995;469-470
27. Hammersley V, Hippisley-Cox J, Wilson A, Pringle M. A comparison of research general practices and their patients with other practices-cross sectional survey in Trent. Br J Gen Pract. 52:2002;463-468
28. Egede LE, Zheng D. Modifiable cardiovascular risk factors in adults with diabetes: prevalence and missed opportunities for physician counseling. Arch Int Med. 162:2002;427-433
29. Khunti K, Ganguli S, Baker R, Lowy A. Features of primary care associated with variations in process and outcomes of care of people with diabetes. Br J Gen Pract. 466:2001;583-584
30. Goyder EC, McNally PG, Drucquer M, Spiers N, Botha JL. Shifting of care for diabetes from secondary to primary care, 1990-5: a review of general practices. BMJ. 316:1998;1505-1506